Form 4: TruBridge Inc. Executive David Harse Reports Stock Grant and Disposal

David Harse, General Manager Patient Care at TruBridge, Inc., reports receiving a stock grant and disposing of shares.

Summary

• On March 13, 2025, David Harse, General Manager Patient Care at TruBridge, Inc., reported a transaction involving the company's common stock.
• Harse acquired 5,835 shares of common stock through a grant.
• The grant is a restricted stock award that vests in three annual installments, starting one year from the grant date.
• Harse also disposed of 20,900 shares.
• Following these transactions, Harse beneficially owns 20,900 shares of TruBridge, Inc.
• The grant of restricted stock is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. The sentiment is neutral as it simply reports facts without expressing opinions or forecasts.

Positives

• The grant of restricted stock to a key executive could be seen as a positive sign, aligning the executive's interests with the long-term performance of the company.

Negatives

• The disposal of 20,900 shares by the executive could be interpreted negatively by some investors, although the reason for disposal is not specified.

Risks

• The disposal of a significant number of shares by an executive could create uncertainty among investors.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's views on the company's prospects.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret the executive's actions.

Key Dates